Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apalutamide in Prostate Cancer Active Surveillance (TAPS01)
NCT03365297Phase 2Completed
- Sponsor
- Cambridge Clinical Trials Unit
- Start
- Jun 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of apalutamide in prostate cancer (PCa), sponsored by Cambridge Clinical Trials Unit. Started Jun 2018; status: completed.
02
Drugs
apalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03365297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365297.